This announcement is a separate document:
聖諾醫藥-B：自願性公告 - Sirnaomics宣佈完成STP707的I期臨床研究，其結果具有較強的安全性和治療胰腺癌患者穩定的疾病活性
SIRNAOMICS-B: VOLUNTARY ANNOUNCEMENT - SIRNAOMICS ANNOUNCES COMPLETION OFSTP707 PHASE I CLINICAL STUDY WITHSTRONG SAFETY PROFILE AND STABLE DISEASE ACTIVITYFOR THE TREATMENT OF PANCREATIC CANCER PATIENTS
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.